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Abstract
Introduction
Previous studies have consistently documented that racial/
ethnic minority patients with diabetes receive lower qual-
ity of care, based on various measures of quality of care 
and  care  settings.  However,  2  recent  studies  that  used 
data from Medicare or Veterans Administration beneficia-
ries have shown improvements in racial/ethnic disparities 
in the quality of diabetes care. These inconsistencies sug-
gest that additional investigation is needed to provide new 
information about the relationship between racial/ethnic 
minority patients and the quality of diabetes care.
Methods
We analyzed 3 years of data (2005-2007) from the Medical 
Expenditure Panel Survey and used multivariate models 
that adjusted for sociodemographic characteristics, region-
al location, insurance status, health behaviors, health sta-
tus, and comorbidity to examine racial/ethnic disparities 
in the quality of diabetes care.
Results
We found that Asian patients with diabetes were less likely 
to have received 2 or more glycated hemoglobin (HbA1c) 
tests or a foot examination during the past year compared 
with their white counterparts. Hispanic patients with diabe-
tes were also less likely to have received a foot examination 
during the past year compared with white patients with 
diabetes.  Conversely,  black  patients  with  diabetes  were 
more likely to have received a foot examination during the 
past year compared with white patients with diabetes. The 
differences in the quality of diabetes care remained signifi-
cant even after controlling for socioeconomic status (SES), 
health insurance status, self-rated health status, comorbid 
conditions, and lifestyle behavior variables.
Conclusions
Although the link between racial/ethnic minority status 
and the quality of care for patients with diabetes is not 
completely  understood,  our  results  suggest  that  factors 
such as SES, health insurance status, self-rated health 
status, and other health conditions are potential anteced-
ents of quality of diabetes care.
Introduction
Although diabetes is a prevalent, debilitating, and costly 
chronic condition that affects the general population, evi-
dence suggests that racial/ethnic minority groups bear a 
disproportionate burden of the condition (1-5). Racial/eth-
nic minority groups have a higher prevalence, worse dia-
betes outcomes, and higher rates of diabetes-related com-
plications than their white counterparts (1-3,6,7). Previous 
studies  have  consistently  documented  that  racial/ethnic 
minority patients with diabetes receive lower quality of 
care, based on various measures of quality of care and care 
settings (8-12). For instance, a report published in 2006 by 
the Agency for Healthcare Research and Quality showed 
that racial/ethnic minority groups, including patients who 
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have diabetes, received poorer quality of care in 22 critical 
measures of quality care compared with whites (13).
However, a recent study that used data from 1997 to 2003 
from Medicare beneficiaries in managed care plans has 
shown that improvements have been made in racial/ethnic 
disparities in the quality of diabetes care (14). Clinical per-
formance for patients with diabetes improved, and the gap 
in the quality of diabetes care between whites and blacks 
narrowed for 7 of the Health Plan Employer Data and 
Information  Set  (HEDIS)  measures,  including  glycated 
hemoglobin  (HbA1c)  and  eye  examination.  Similarly,  a 
more  recent  study  that  used  nationally  representative 
data from the Medical Expenditures Panel Survey (MEPS) 
found no significant differences in the quality of diabetes 
care  between  racial/ethnic  minority  groups  and  white 
patients (15).
Additional  studies  that  examined  the  Medicare  and 
Veterans Administration (VA) populations have suggested 
that  recent  investment  in  public  resources  to  address 
racial/ethnic inequalities in health and health care may 
have resulted in the reduction or elimination of racial/eth-
nic disparities in the quality of diabetes care (14,16,17). 
The results of these 2 studies are encouraging but cannot 
be generalized to the US population because of systematic 
differences between the general population and Medicare 
or  VA  beneficiaries.  These  inconsistencies  also  suggest 
that  additional  investigation  is  needed  to  provide  new 
information about the relationship between racial/ethnic 
minority groups and the quality of diabetes care.
Racial/ethnic  differences  in  the  quality  of  diabetes  care 
may arise from multiple factors and complex interactions 
between patients, their providers, and the health care sys-
tems in which they operate (18). Therefore, we investigated 
factors that are amenable to policy changes in our models, 
including socioeconomic status (SES) and health insurance 
coverage, to determine racial/ethnic differences in the qual-
ity of diabetes care. Our objective was to examine racial/
ethnic disparities in the quality of care provided to patients 
with diabetes by using nationally representative data sets.
Methods
Sample
We  analyzed  3  years  of  data  (2005-2007)  from  MEPS, 
a  nationally  representative  survey  of  health  services 
use,  health  insurance  coverage,  medical  expenditures, 
and  sources  of  payment  for  the  US  civilian  noninstitu-
tionalized population that is cosponsored by the Agency 
for  Healthcare  Research  and  Quality  and  the  National 
Center for Health Statistics. For this analysis, we used the 
household component (HC) file of MEPS, which is the core 
component of the survey that collects data on demographic 
characteristics, health conditions, self-rated health status, 
medical services use, access to care, satisfaction with care, 
health  insurance  coverage  status,  and  income  for  each 
person surveyed.
We pooled 3 years of data to increase the sample size of the 
study and used a study design that attempted to address 
previous  shortcomings  and  inconsistencies  in  the  lit-
erature. The overlapping design of MEPS allows repeated 
observations of the same people several times during the 
year. We combined data from the HC files with the pooled 
estimation linkage file of MEPS to restrict the analytic 
sample to unique individuals. By restricting the sample in 
this way, we were able to compute appropriate standard 
errors.  To  construct  the  analytic  sample  we  used  data 
from the MEPS Diabetes Care Survey, a self-administered 
questionnaire to adult respondents aged 18 years or older 
who reported that they had been diagnosed with diabetes 
by a health care professional. This survey contains a series 
of questions about diabetes management for 2005, 2006, 
and  2007,  including  the  number  of  times  respondents 
reported having had an HbA1c test, the number of times 
they reported having had their feet checked for sores or 
irritation, and the last time they reported having had an 
eye examination during the same period.
The  resulting  sample  was  2,671  people  who  reported 
that they had been diagnosed with diabetes by a health 
care professional during the 3 years combined. We sub-
sequently excluded 182 people, either because they did 
not respond to the self-administered questionnaire them-
selves  or  did  not  have  any  office  visit  during  the  time 
of the study. We limited the analytic sample to people 
who responded to the self-administered questionnaire by 
themselves, not by their spouse or another proxy, to limit 
reporting bias and included only patients with diabetes 
who had at least 1 visit to a health care professional dur-
ing the past 12 months to capture patient-provider inter-
actions in measuring the quality of care for patients with 
diabetes.  Finally,  we  excluded  an  additional  37  people 
who had missing observations on the different variables 
used in the analysis. The final analytic sample was 2,452 
patients who reported that they had been diagnosed with VOLUME 8: NO. 6
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diabetes by a health care professional and were aged 18 
years or older.
Variables
Consistent with American Diabetes Association guidelines 
for patients with diabetes, we used 3 binary indicators to 
measure quality of care for patients with diabetes, which 
were  reporting  receipt  of  the  following  during  the  past 
year:  1)  2  or  more  HbA1c  tests,  2)  1  foot  examination, 
and 3) 1 eye examination. For the HbA1c tests, MEPS 
asked, “During [survey year], how many times did a doc-
tor, nurse, or other health professional check your blood 
for glycosylated hemoglobin or ‘hemoglobin A-one-C’?” For 
the foot examination, MEPS asked, “How many times did 
a health professional check your feet for any sores or irrita-
tions?” For the eye examination, MEPS asked, “In which 
year did you have an eye examination in which your pupils 
were dilated?”
On the basis of previous research, we controlled for a set of 
patient characteristics known to be associated with differ-
ences in quality of care including age, race/ethnicity, sex, 
SES, health insurance status, smoking status, obesity sta-
tus, general health status, comorbid cardiovascular condi-
tions,  and  regional  location  (19-21).  To  assess  patients’ 
race/ethnicity, respondents were asked, “Which of these 
would  you  say  is  your  main  racial  or  ethnic  group?” 
Response options were non-Hispanic white, non-Hispanic 
African American, Hispanic, American Indian or Alaska 
Native,  Asian  or  Pacific  Islander,  mixed  race,  or  some 
other single race. From these responses, we constructed 4 
categories: non-Hispanic white, black, Hispanic, and Asian. 
We used the MEPS body mass index (BMI) measure, cal-
culated from respondents’ self-reported height and weight, 
to create an indicator variable for obesity (BMI ≥30 kg/m2). 
Different categories of education and income were used to 
account for the nonlinearity of the relationship between 
these  2  variables  and  the  quality  of  care  for  patients 
with diabetes. Education levels were defined as receiving 
less than a high school degree, high school degree, col-
lege degree, or postgraduate degree. Income levels were 
defined  as  incomes  below  100%  of  the  federal  poverty 
level (FPL), between 100% and 199% of the FPL, between 
200% and 400% of the FPL, and above 400% of the FPL. 
Comorbid cardiovascular conditions included patients who 
reported being diagnosed with at least 1 of the following 
conditions: hypertension, angina, mild or coronary heart 
attack, stroke, or other form of heart disease.
Statistical analysis
We used logistic regression models to determine the odds 
of receiving at least 2 HbA1c tests, a foot examination, or 
an eye examination in the past year. We conducted χ2 tests 
to determine differences in outcomes among the different 
racial/ethnic minority groups. Significance was set at P < 
.10. Because of the complex survey design of the MEPS 
HC file, we used special diabetes weights from MEPS to 
compute robust standard errors of the estimates. Because 
we  pooled  data  over  several  years  for  a  subsample  of 
patients with diabetes, we used the balanced repeated rep-
lication method of variance estimation to account for the 
full set of survey stratum and primary sampling units, as 
recommended by MEPS. Weighted proportions, adjusted 
odds  ratios  (AORs),  and  95%  confidence  intervals  (CIs) 
were used to present the results. We used Stata version 
11 (StataCorp LP, College Station, Texas) to conduct the 
analysis.
Results
More than 68% of respondents were aged 55 years or older, 
34% of respondents resided in families with incomes high-
er than 400% of the FPL, and 31% had some form of public 
insurance such as Medicaid or Medicare. Approximately 
78% of the sample had other comorbid cardiovascular con-
ditions (Table 1).
On average, about 83% of patients reported receiving at 
least 2 HbA1c tests; 70%, a foot examination; and 61%, an 
eye examination during the past 12 months. Chi-square 
tests indicated significant differences between whites and 
Asians receiving at least 2 HbA1c tests (P = .007) and a 
foot examination (P = .002) (Table 2). Hispanic patients 
were less likely to receive an eye examination during the 
past year than were white patients (P = .005). Conversely, 
black patients were more likely to receive a foot examina-
tion than were white patients (P = .009) and less likely to 
receive an eye examination than were white patients (P = 
.03) during the past year.
Multivariate  logistic  regression  analyses  indicated  that 
Asian patients with diabetes were less likely to receive at 
least 2 HbA1c tests or a foot examination in the past year 
than were their white counterparts (Table 3). Likewise, 
Hispanic patients with diabetes were less likely to receive 
a foot examination in the past 12 months than were white 
patients  with  diabetes.  Conversely,  black  patients  with VOLUME 8: NO. 6
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diabetes were more likely to receive a foot examination 
than were white patients with diabetes.
High school graduates were less likely to receive at least 2 
HbA1c tests or a foot examination compared with partici-
pants who did not graduate from high school. Similarly, 
patients with diabetes who resided in the Midwest, South, 
or West were less likely to receive a foot examination than 
were those who lived in the northeastern part of the coun-
try. We also found negative associations between receipt of 
eye examination and patients who were uninsured or who 
smoked compared with those who were privately insured 
or did not smoke, respectively. Patients who resided in 
families with incomes more than 400% of the FPL, were 
in fair or poor health, and suffered from comorbid cardio-
vascular conditions were more likely to report receiving 
HbA1c tests compared with those who lived in families 
with incomes below 100% of the FPL, were in excellent or 
good health, and did not have a comorbid cardiovascular 
condition. For example, patients with a comorbid cardio-
vascular condition were 34% more likely to have received 
2 or more HbA1c tests than were those who did not.
Patients  who  resided  in  families  with  an  income  above 
400%  of  the  FPL,  were  publicly  insured  with  either 
Medicaid or Medicare, reported fair/poor health, or had 
a comorbid cardiovascular condition were more likely to 
have a foot examination compared with those who lived 
in  families  with  incomes  below  100%  of  the  FPL,  were 
privately insured, were in excellent/good health, or did not 
have a cardiovascular comorbid condition. Patients who 
had incomes greater than 400% of the FPL were more like-
ly to receive a foot examination than patients who lived in 
families with incomes below 100% of the FPL.
Discussion
Our  study  advances  the  literature  on  racial/ethnic  dis-
parities in quality of care for patients with diabetes. We 
assessed racial/ethnic disparities in the quality of diabetes 
care on the basis of receipt of recommended HbA1c tests 
and foot and eye examinations in the previous year. We 
hypothesized  that  racial/ethnic  minority  patients  with 
diabetes  would  receive  lower  quality  of  care  than  their 
white counterparts. Compared with white patients with 
diabetes, Asian patients with diabetes were less likely to 
have received at least 2 HbA1c tests and both Asian and 
Hispanic patients were less likely to have received a foot 
examination  in  the  past  12  months.  Conversely,  black 
patients with diabetes were more likely to have received 
a  foot  examination  in  the  past  12  months  compared 
with white patients with diabetes. This finding may be 
explained  by  the  fact  that  black  patients  with  diabetes 
tend to have higher rates of diabetes complications and 
amputations, and recent guidelines have highlighted the 
need to carefully monitor these patients as their conditions 
progress (22). These differences remained significant even 
after controlling for SES, insurance status, health status, 
comorbid conditions, and lifestyle behavior variables.
However, our results differ from those found by Lee and 
colleagues (19), who found no differences in receipt of these 
measures among racial/ethnic minorities. Their analysis 
of  2000  MEPS  data  found  no  differences  among  racial/
ethnic groups for most of the outcomes in diabetes care 
management, including respondents who had received an 
HbA1c test, had their feet checked for sores or irritation, 
or received an eye examination in the past year. A possible 
explanation for the different findings may be differences 
in study design. Contrary to the study conducted by Lee 
et al (19), we restricted our sample to unique individuals 
to compute appropriate standard errors in pooled estima-
tions. Additional differences were the use of more recent 
data sets, the use of special diabetes weights from MEPS, 
and the use of the balanced repeated replication method 
variance estimation to account for the full set of survey 
stratum  and  primary  sampling  units,  as  recommended 
by MEPS (23). Our results also differ from findings of a 
study by Trivedi et al that found narrowing of the gap in 
the quality of diabetes care between whites and blacks 
(14). However, this study was limited to Medicare benefi-
ciaries in managed care, and the authors did not stratify 
by other racial/ethnic minority groups such as Hispanics 
and Asians. The findings by Trivedi et al may not be gen-
eralizable to other health systems or to other racial/ethnic 
groups that may experience greater racial/ethnic dispari-
ties in the quality of diabetes care. Conversely, our find-
ings are consistent with those of other studies that used 
both clinical and community-based data (24-29).
Our study has limitations. First, the data we used were 
cross-sectional,  so  causal  relationships  cannot  be  estab-
lished. Second, the dependent variables were self-reported 
measures of process outcomes of diabetes care. Although 
we controlled for patients who reported poor or fair health 
or comorbid cardiovascular conditions, these patients may 
have  visited  their  providers  more  often  and  thus  were 
more likely to receive diabetes tests compared with those 
who reported excellent or good health and no comorbid VOLUME 8: NO. 6
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cardiovascular conditions. Furthermore, no information on 
glycemic control among patients with diabetes was avail-
able. Asians may have better glycemic control and may 
have received HbA1c tests and foot and eye examinations 
less frequently than their white counterparts.
Although the link between racial/ethnic minority status 
and the quality of care for patients with diabetes is not 
completely  understood,  our  study  suggests  that  factors 
such  as  health  insurance  status,  SES,  and  self-rated 
health status are potential antecedents of quality of dia-
betes care. Therefore, assessing the association between 
racial/ethnic  disparities  in  the  quality  of  diabetes  care 
and  factors  such  as  SES,  insurance  status,  and  health 
behaviors is warranted because these factors are modifi-
able and can serve as the focus of interventions to reduce 
racial/ethnic  disparities  in  the  quality  of  diabetes  care. 
Findings from this study may have clinical, public health, 
public policy, and research implications. Specifically, these 
results may underscore the importance of providing diver-
sity training to providers to improve the quality of care to 
patients with diabetes. Furthermore, evidence from this 
study may play a key role in informing policy makers in 
their continuous efforts to translate effective research into 
nationwide practices to eliminate racial/ethnic differences 
in quality of care, which is relevant in the context of the 
current  health  care  reform  law  that  seeks  to  eliminate 
racial/ethnic disparities. Additional research is needed to 
fully evaluate the mechanisms and sources of racial/ethnic 
disparities in the quality of diabetes care.
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Tables
Table 1. Dependent and Independent Variables for Racial/Ethnic Disparities in the Quality of Care for Patients Aged 18 to 64 Years 
With Diabetes (n = 2,452), 2005-2007 Medical Expenditure Panel Surveya
Characteristics Weighted %b
Dependent Variables
Clinical testing
Received ≥2 HbA1c tests in past year 8.2
Received foot examination in past year 70.9
Received eye examination in past year 61.1
Independent Variables
Female sex 2.1
Age, y
18-24 0.6
2-4 2.7
-44 9.
4-4 18.
-64 0.
6-74 19.9
≥75 18.
Race/ethnicity
Non-Hispanic white 68.2
Black 1.0
Hispanic 1.2
Asian .6
Education
Less than a high school degree .0
High school degree 1.0
College degree 10.6
Postgraduate degree .4
Characteristics Weighted %b
Independent Variables (continued)
Income as % of FPLc
<100 14.1
100-199 21.2
200-400 1.0
>400 .7
Insurance status
Private insurance 62.7
Public insurance 1.2
Uninsured 6.1
Health status/conditions
Fair/poor health 9.7
Obesed 4.7
Comorbid cardiovascular conditionse 77.8
Current smoker 1.
Region
Northeast 19.1
Midwest 21.
South 9.4
West 21.2
 
Abbreviations: HbA1c, glycated hemoglobin; FPL, federal poverty level. 
a Data are pooled for years 200, 2006, and 2007 of the Household 
Component of the Medical Expenditure Panel Survey (MEPS). The sample 
was restricted to unique individuals in each year of the pooled data. There 
are no repeated observations for the same individual across the different 
years. 
b Percentages weighted to yield a nationally representative sample of US 
households. 
c FPL is the set minimum amount of income that a family needs for food, 
clothing, transportation, shelter and other necessities and is used to deter-
mine eligibility income limits for public assistance programs as some per-
centage of FPL. FPL varies according to family size and is determined by the 
US Department of Health and Human Services. 
d Reported body mass index of ≥30 kg/m2. 
e Respondents with any of the following conditions: hypertension, angina, 
mild or coronary heart attack, stroke, or other form of heart disease.VOLUME 8: NO. 6
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Table 2. Weighted Proportions Receiving 2 HbA1c Tests, Foot Examination, and Eye Examination in the Past Year, by Racial/Ethnic 
Minority Group, Adult Patients Aged 18 to 64 Years With Diabetes (n = 2,452), 2005-2007 Medical Expenditure Panel Surveya
Race/ethnicity
Weighted %b (95% CI)
Received ≥2 HbA1c Tests in Past Year Received Foot Examination in Past Year Received Eye Examination in Past Year
White 8.0 (80.-8.8) 71.2 (67.6-74.9) 6. (9.2-67.6)
Black 84. (79.1-89.9) 76.9 (71.4-82.) .1 (4.1-61.2)
Hispanic 77.8 (71.4-9.6) 6.1 (6.1-70.2) 2.6 (4.7-9.)
Asian 8. (71.1-9.6) 70.2 (.-86.9) 7.9 (8.8-92.9)
 
Abbreviations: CI, confidence interval; HbA1c, glycated hemoglobin. 
a Data are pooled for years 200, 2006, and 2007 of the Household Component of the Medical Expenditure Panel Survey (MEPS). The sample was restricted 
to unique individuals in each year of the pooled data. There are no repeated observations for the same individual across the different years. 
b Percentage is weighted to yield a nationally representative sample of US households.
Table 3. Logistic Regression Results for Racial/Ethnic Disparities in the Quality of Care for Patients with Diabetes (n = 2,452), by 
Quality Indicators, 2005-2007 Medical Expenditure Panel Surveya
Independent Variable
Received ≥2 HbA1C Tests in the Past 
Year
Received Foot Examination in the 
Past Year
Received Eye Examination in the Past 
Year
AOR (95% CI) P Value AOR ( 95% CI) P Value AOR (95% CI) P Value
Female sex 1.14 (0.96-1.) .1 1.10 (0.90-1.) .4 1.14 (0.9-1.40) .20
Age, y
18-24 1 [Reference]
2-4 0.1 (0.06-2.6) .84 0.41 (0.0-2.2) .82 0.44 (0.06-2.44) .81
-44 0.81 (0.10-2.6) .9 0.66 (0.08-2.6) .92 0.4 (0.09-2.72) .82
4-4 0.90 (0.14-.6) .97 0.64 (0.1-.41) .91 0.8 (0.1-.4) .87
-64 0.97 (0.16-4.08) .99 0.74 (0.1-4.09) .94 0.6 (0.16-4.1) .90
6-74 0.7 (0.12-.41) .9 0.79 (0.10-.4) .9 0.68 (0.1-.4) .91
≥75 0.82 (0.12-.4) .9 0.8 (0.11-.) .97 0.8 (0.11-.40) .96
Race/ethnicity
Non-Hispanic white 1 [Reference]
Black 1.10 (0.8-1.42) .48 1.1 (1.00-1.72) .0 0.86 (0.6-1.17) .
Hispanic 1.1 (0.87-1.46) . 0.76 (0.7-1.0) .08 0.80 (0.60-1.06) .11
Asian 0.44 (0.20-0.98) .04 0. (0.1-0.81) .02 0.67 (0.-1.8) .27
 
Abbreviations: HbA1c, glycated hemoglobin; AOR, adjusted odds ratio; CI, confidence interval; FPL, federal poverty level. 
a Data are pooled for the 200, 2006, and 2007 waves of the household component of the Medical Expenditure Panel Survey. The sample was restricted to 
unique individuals in each of the rounds of the pooled data. There are no repeated observations for the same individual across the different rounds of the 
year. 
b The set minimum amount of income that a family needs for food, clothing, transportation, shelter and other necessities and is used to determine eligibil-
ity income limits for public assistance programs as some percentage of FPL. FPL varies according to family size and is determined by the US Department of 
Health and Human Services.
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Independent Variable
Received ≥2 HbA1C Tests in the Past 
Year
Received Foot Examination in the 
Past Year
Received Eye Examination in the Past 
Year
AOR (95% CI) P Value AOR ( 95% CI) P Value AOR (95% CI) P Value
Education 
No high school degree 1 [Reference]
High school degree 0.81 (0.66-1.00) .0 0.80 (0.6-0.99) .04 1.16 (0.91-1.47) .22
College degree 1.11 (0.77-1.60) .6 0.97 (0.62-1.0) .87 1. (1.0-2.22) .0
Graduate degree 0.98 (0.62-1.4) .9 1.11 (0.61-2.00) .7 0.92 (0.1-1.64) .77
Income as % of FPLb
<100 1 [Reference]
100-199 1.1 (0.84-1.7) .9 1.04 (0.79-1.8) .77 1.21 (0.89-1.6) .22
200-400 1.29 (0.91-1.84) .1 1.00 (0.72-1.40) .99 1.4 (1.0-2.04) .04
>400 1.2 (0.99-1.76) .06 1.6 (1.00-1.8) .0 1.81 (1.18-2.77) .01
Insurance status
Private insurance 1 [Reference]
Public insurance 1.02 (0.8-1.24) .86 1. (1.0-1.68) .02 0.94 (0.72-1.21) .61
Uninsured 0.91 (0.6-1.26) . 0.78 (0.-1.1) .21 0.48 (0.2-0.72) .001
Health status/conditions
Fair/poor health 1.22 (0.98-1.) .08 1.7 (1.10-1.71) .01 0.96 (0.77-1.19) .70
Obese 1.0 (0.86-1.24) .74 1.0 (0.87-1.28) .60 1.0 (0.80-1.) .80
Cardiovascular comorbidity 1.4 (1.04-1.71) .02 1.9 (1.0-1.87) .0 1.24 (0.88-1.74) .21
Current smoker 1.01 (0.78-1.1) .92 1.08 (0.81-1.4) .61 0.72 (0.-0.9) .01
Region 
Northeast 1 [Reference]
Midwest 1.01 (0.69-1.48) .97 0.61 (0.4-0.87) .01 0.96 (0.69-1.) .81
South 0.91 (0.67-1.24) .6 0.69 (0.4-0.89) .004 0.79 (0.6-1.1) .19
West 0.82 (0.6-1.20) .0 0.78 (0.60-1.01) .06 0.84 (0.62-1.14) .26
 
Abbreviations: HbA1c, glycated hemoglobin; AOR, adjusted odds ratio; CI, confidence interval; FPL, federal poverty level. 
a Data are pooled for the 200, 2006, and 2007 waves of the household component of the Medical Expenditure Panel Survey. The sample was restricted to 
unique individuals in each of the rounds of the pooled data. There are no repeated observations for the same individual across the different rounds of the 
year. 
b The set minimum amount of income that a family needs for food, clothing, transportation, shelter and other necessities and is used to determine eligibil-
ity income limits for public assistance programs as some percentage of FPL. FPL varies according to family size and is determined by the US Department of 
Health and Human Services.
Table 3. (continued) Logistic Regression Results for Racial/Ethnic Disparities in the Quality of Care for Patients with Diabetes (n = 
2,452), by Quality Indicators, 2005-2007 Medical Expenditure Panel Surveya